Equipment has been designed and constructed to produce pharmaceutical microspheres in the microgravitational environment found aboard an orbiting U.S. Space Shuttle. The microcapsules in space (MIS) equipment will replace two space shuttle middeck storage lockers. Design changes have been incorporated into the MIS equipment reflecting the results of NASA mandated safety tests. MIS is tentatively manifested aboard the Space Shuttle Discovery on Mission STS-53 pending final safety certification by NASA. STS-53 is scheduled for launch on October 15, 1992. RA 2; Microencapsulation; Controlled-release; Space Shuttle; Antibiotics; Drug development.


    Zugriff

    Zugriff über TIB

    Verfügbarkeit in meiner Bibliothek prüfen


    Exportieren, teilen und zitieren



    Titel :

    Microencapsulation of Drugs in the Microgravity Environment of the United States Space Shuttle


    Beteiligte:
    T. R. Tice (Autor:in) / R. J. Holl (Autor:in)

    Erscheinungsdatum :

    1992


    Format / Umfang :

    26 pages


    Medientyp :

    Report


    Format :

    Keine Angabe


    Sprache :

    Englisch





    Microgravity Environment of the Space Shuttle Columbia Middeck During STS-32

    B. J. Dunbar / D. A. Thomas / J. N. Schoess | NTIS | 1991


    The microgravity environment of the Space Shuttle Columbia middeck during STS-32

    Dunbar, Bonnie J. / Thomas, Donald A. / Schoess, Jeff N. | NTRS | 1991


    Microgravity Environment of the Space Shuttle Columbia Payload Bay During STS-32

    B. J. Dunbar / R. L. Giesecke / D. A. Thomas | NTIS | 1991


    Microgravity Forward Smolder Experiments in the Space Shuttle

    Bar-Ilan, A. / Rein, G. / Fernandez-Pello, A. C. et al. | British Library Conference Proceedings | 2003